MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched its Mobius ADC Reactor, a single-use reactor specifically designed for the production of antibody drug conjugates (ADCs). ADCs, a rapidly growing class of therapeutic agents, offer targeted and selective killing of tumor cells while minimizing harm to healthy tissues.   The Mobius ADC Reactor addresses the unique challenges associated with ADC manufacturing, providing biopharmaceutical com...